Copyright © 1987 by the European Society of Cardiology.
© 1987 The European Society of Cardiology
Chronic atrial fibrillation— epidemiologic features and 14 year follow-up: A case control study
Departments of Medicine and Radiology, Landspitalinn, University Hospital of Iceland and Heart Preventive Clinic Reykjavik, Iceland
Received 14 July 1986; revised 16 October 1986; .
G. Thorgeirsson, M.D., Ph.D., Department of Medicine, Landspitalinn, University Hospital of Iceland, Reykjavik, Iceland.
Abstract
In a randomly selected population of 9067 individuals, 32–64 years of age in 1967–1970, 25 (0.28%) had chronic atrial fibrillation (CAF). Eight had lone atrial fibrillation. In 1984 the cases were compared with an age- and sex-matched control group of 50 and found to have more cerebrovascular accidents (6 versus 2; P < 0.05), congestive heart failure (9 versus 1; P < 0.001), and valvular rheumatic heart disease (3 versus 0) or history consistent with rheumatic fever (6 versus 0; P < 0.01). The mortality in the CAF group was 60% higher due to an excess in cardiovascular (relative risk 6.1; P<0.05) and cerebrovascular (relative risk 12.2; P<0.05) causes. The prevalence or incidence of ischaemic or hypertensive heart disease or the presence of coronary risk factors did not significantly differ in the two groups. By M-mode echocardiography the left atrial size, left ventricular enddiastolic dimension and left ventricular mass were increased in the CAF patients, while the systolic left ventricular shortening was significantly less.
Thus, the prevalence of CAF is low in a randomly selected population 32–64 years of age and CAF is not strongly associated with ischaemic heart disease or hypertension. The CAF patients have an increased risk of dying prematurely particularly from cerebrovascular causes, even in the absence of valve disease.
Key Words: Chronic atrial fibrillation • epiderniologic survey • clinical follow-up • echocardigraphy
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Miyasaka, M. E. Barnes, B. J. Gersh, S. S. Cha, K. R. Bailey, W. Abhayaratna, J. B. Seward, T. Iwasaka, and T. S.M. Tsang Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decades Eur. Heart J., April 2, 2006; 27(8): 936 - 941. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Heeringa, D. A.M. van der Kuip, A. Hofman, J. A. Kors, G. van Herpen, B. H.Ch. Stricker, T. Stijnen, G. Y.H. Lip, and J. C.M. Witteman Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study Eur. Heart J., April 2, 2006; 27(8): 949 - 953. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Dunn, J. Wisnivesky, W. Ho, C. Moore, T. McGinn, and H. S. Sacks Perioperative Management of Patients on Oral Anticoagulants: A Decision Analysis Med Decis Making, July 1, 2005; 25(4): 387 - 397. [Abstract] [PDF]
|
|
|
|
 |
|
 B. Ruo, A. M. Capra, N. G. Jensvold, and A. S. Go Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study J. Am. Coll. Cardiol., February 4, 2004; 43(3): 429 - 435. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Bertaglia, F Zoppo, A Bonso, A Proclemer, R Verlato, L Coro, R Mantovan, D D'Este, F Zerbo, and P Pascotto Long term follow up of radiofrequency catheter ablation of atrial flutter: clinical course and predictors of atrial fibrillation occurrence Heart, January 1, 2004; 90(1): 59 - 63. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Aviles, D. O. Martin, C. Apperson-Hansen, P. L. Houghtaling, P. Rautaharju, R. A. Kronmal, R. P. Tracy, D. R. Van Wagoner, B. M. Psaty, M. S. Lauer, et al. Inflammation as a Risk Factor for Atrial Fibrillation Circulation, December 16, 2003; 108(24): 3006 - 3010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R Kasliwal, S. Mukesh, G. Manohar, N. Aggarwal, and A. Bhatia Pharmacotherapy of Atrial Fibrillation Asian Cardiovasc Thorac Ann, December 1, 2003; 11(4): 364 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Wang, J. M. Massaro, D. Levy, R. S. Vasan, P. A. Wolf, R. B. D'Agostino, M. G. Larson, W. B. Kannel, and E. J. Benjamin A Risk Score for Predicting Stroke or Death in Individuals With New-Onset Atrial Fibrillation in the Community: The Framingham Heart Study JAMA, August 27, 2003; 290(8): 1049 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-P. Lai, C.-C. Tsai, M.-J. Su, J.-L. Lin, Y.-S. Chen, Y.-Z. Tseng, and S. K. S. Huang Atrial Fibrillation Is Associated With Accumulation of Aging-Related Common Type Mitochondrial DNA Deletion Mutation in Human Atrial Tissue Chest, February 1, 2003; 123(2): 539 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Cox Surgical Treatment of Supraventricular Tachyarrhythmias Card. Surg. Adult, January 1, 2003; 2(2003): 1271 - 1286. [Full Text]
|
|
|
|
|
|
E. Bertaglia, D. D'Este, F. Zerbo, F. Zoppo, P. Delise, and P. Pascotto Success of serial external electrical cardioversion of persistent atrial fibrillation in maintaining sinus rhythm. A randomized study Eur. Heart J., October 1, 2002; 23(19): 1522 - 1528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Grigioni, J.-F. Avierinos, L. H. Ling, C. G. Scott, K. R. Bailey, A. J. Tajik, R. L. Frye, and M. Enriquez-Sarano Atrial fibrillation complicating the course of degenerative mitral regurgitation: Determinants and long-term outcome J. Am. Coll. Cardiol., July 3, 2002; 40(1): 84 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Stewart, C L Hart, D J Hole, and J J V McMurray Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study Heart, November 1, 2001; 86(5): 516 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. BERTAGLIA, D. D'ESTE, A. ZANOCCO, F. ZERBO, and P. PASCOTTO Effects of pretreatment with verapamil on early recurrences after electrical cardioversion of persistent atrial fibrillation: a randomised study Heart, May 1, 2001; 85(5): 578 - 580. [Full Text]
|
|
|
|
|
|
A.U Khand, A.C Rankin, G.C Kaye, and J.G.F Cleland Systematic review of the management of atrial fibrillation in patients with heart failure Eur. Heart J., April 2, 2000; 21(8): 614 - 632. [Abstract] [PDF]
|
|
|
|
|
|
A E Tuinenburg, I C Van Gelder, M P V. Den Berg, J Brugemann, P J De Kam, and H J G M Crijns Lack of prevention of heart failure by serial electrical cardioversion in patients with persistent atrial fibrillation Heart, October 1, 1999; 82(4): 486 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Jouven, M. Desnos, C. Guerot, and P. Ducimetiere Idiopathic atrial fibrillation as a risk factor for mortality.The Paris Prospective Study I Eur. Heart J., June 2, 1999; 20(12): 896 - 899. [Abstract] [PDF]
|
|
|
|
|
|
L.-P. Lai, M.-J. Su, J.-L. Lin, F.-Y. Lin, C.-H. Tsai, Y.-S. Chen, S. K. S. Huang, Y.-Z. Tseng, and W.-P. Lien Down-regulation of L-type calcium channel and sarcoplasmic reticular Ca2+-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: An insight into the mechanism of atrial electrical remodeling J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1231 - 1237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.A. Goudevenos, J.N. Vakalis, V. Giogiakas, P. Lathridou, C. Katsouras, L.K. Michalis, and D.A. Sideris An epidemiological study of symptomatic paroxysmal atrial fibrillation in northwest Greece Europace, January 1, 1999; 1(4): 226 - 233. [Abstract] [PDF]
|
|
|
|
|
|
E. J. Benjamin, P. A. Wolf, R. B. D'Agostino, H. Silbershatz, W. B. Kannel, and D. Levy Impact of Atrial Fibrillation on the Risk of Death : The Framingham Heart Study Circulation, September 8, 1998; 98(10): 946 - 952. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Izumoto, K. Kawazoe, H. Kitahara, and J. Kamata Operative results after the Cox/maze procedure combined with a mitral valve operation Ann. Thorac. Surg., September 1, 1998; 66(3): 800 - 804. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N M Wheeldon, D I Tayler, E Anagnostou, D Cook, C Wales, and G D G Oakley Screening for atrial fibrillation in primary care Heart, January 1, 1998; 79(1): 50 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Yue, J. Feng, R. Gaspo, G.-R. Li, Z. Wang, and S. Nattel Ionic Remodeling Underlying Action Potential Changes in a Canine Model of Atrial Fibrillation Circ. Res., October 19, 1997; 81(4): 512 - 525. [Abstract] [Full Text]
|
|
|
|
|
|
R. G. Tieleman, C. D. J. De Langen, I. C. Van Gelder, P. J. de Kam, J. Grandjean, K. J. Bel, M. C. E. F. Wijffels, M. A. Allessie, and H. J. G. M. Crijns Verapamil Reduces Tachycardia-Induced Electrical Remodeling of the Atria Circulation, April 1, 1997; 95(7): 1945 - 1953. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. Gallik, J. Altamirano, and B. N. Singh Review : Restoring Sinus Rhythm in Patients with Atrial Flutter and Fibrillation: Pharmacologic or Electrical Cardioversion? Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(2): 135 - 144. [Abstract] [PDF]
|
|
|
|
|
|
A. Elvan, H. P. Pride, J. N. Eble, and D. P. Zipes Radiofrequency Catheter Ablation of the Atria Reduces Inducibility and Duration of Atrial Fibrillation in Dogs Circulation, April 15, 1995; 91(8): 2235 - 2244. [Abstract] [Full Text]
|
|
|
|
|
|
C. A. Morillo, G. J. Klein, D. L. Jones, and C. M. Guiraudon Chronic Rapid Atrial Pacing : Structural, Functional, and Electrophysiological Characteristics of a New Model of Sustained Atrial Fibrillation Circulation, March 1, 1995; 91(5): 1588 - 1595. [Abstract] [Full Text]
|
|
|
|
|
|
Z. Blanck, A. A. Dhala, J. Sra, S. S. Deshpande, A. J. Anderson, M. Akhtar, and M. R. Jazayeri Characterization of Atrioventricular Nodal Behavior and Ventricular Response During Atrial Fibrillation Before and After a Selective Slow-Pathway Ablation Circulation, February 15, 1995; 91(4): 1086 - 1094. [Abstract] [Full Text]
|
|